These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19829143)

  • 1. Cardiac resynchronization therapy: back to ECG?
    Gianfranchi L; Alboni P
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):145-50. PubMed ID: 19829143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting CRT candidates: the value of intracardiac mapping.
    Kautzner J; Peichl P
    Europace; 2008 Nov; 10 Suppl 3():iii106-9. PubMed ID: 18955390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical dyssynchrony from the perspective of a cardiac electrophysiologist.
    Beshai JF; Khunnawat C; Lin AC
    Curr Opin Cardiol; 2008 Sep; 23(5):447-51. PubMed ID: 18670255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of strategies for guiding cardiac resynchronization therapy.
    Rademakers LM; de Boeck BW; Maessen JG; Prinzen FW
    Heart Fail Clin; 2008 Jul; 4(3):333-45. PubMed ID: 18598985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the pathophysiological basics of cardiac resynchronization therapy.
    Auricchio A; Prinzen FW
    Europace; 2008 Jul; 10(7):797-800. PubMed ID: 18482999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure.
    Rosanio S; Schwarz ER; Ahmad M; Jammula P; Vitarelli A; Uretsky BF; Birnbaum Y; Ware DL; Atar S; Saeed M
    Am J Cardiol; 2005 Sep; 96(5):710-7. PubMed ID: 16125501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy through biventricular pacing in patients with heart failure and ventricular dyssynchrony.
    Albert NM
    Crit Care Nurse; 2003 Jun; 23(3 Suppl):2-13; quiz 15-6. PubMed ID: 12830691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of a positive response to biventricular pacing in patients with severe heart failure and ventricular conduction delay.
    Yeim S; Bordachar P; Reuter S; Laborderie J; O'Neill MD; Lafitte S; Deplagne A; Garrigue S; Roudaut R; Jais P; Haissaguerre M; Dossantos P; Clementy J
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):970-5. PubMed ID: 17669079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T wave oversensing and low percentage of biventricular pacing in cardiac resynchronization therapy.
    Lezcano AO; Aracama JM; Ayestaran VU; Urra FG
    Cardiol J; 2009; 16(6):580-1. PubMed ID: 19950098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of inter- and intraventricular conduction abnormalities in patients eligible for cardiac resynchronization therapy.
    Peichl P; Kautzner J; Cihák R; Bytesník J
    Pacing Clin Electrophysiol; 2004 Aug; 27(8):1105-12. PubMed ID: 15305960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy: overcoming ventricular dyssynchrony in dilated heart failure.
    Kerwin WF; Paz O
    Cardiol Rev; 2003; 11(4):221-39. PubMed ID: 12852801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.